Canalevia®-CA1 is the first and only treatment for CID in dogs to receive any type of approval from FDASAN FRANCISCO,…
Proxima CRO recognized with two platinum awards, two gold awards, and five honorable mentions for its creative branding, marketing, and…
CAMBRIDGE, MA / ACCESSWIRE / April 27, 2022 / Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics…
IN A BID TO EXPAND JUPITER WELLNESS'S RESEARCH CAPABILITIES AND ENTER THE LUCRATIVE CRO BUSINESS, JUPITER WELLNESS ACQUIRED THE ASSETS…
Board Member/Acting CEO Provides Shareholder UpdateSale of Engineered Skin Substitute (ESS) subsidiary, Cutanogen Corporation.Emphasis placed on advancing Elto Pharma, Inc.…
First-Quarter 2022 ResultsConsolidated revenue increased 1% to $117 million; excluding 2021 COVID-19 PCR testing revenue, consolidated revenue increased 3%Clinical Services…
ANN ARBOR, MI / ACCESSWIRE / April 27, 2022 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics…
PALO ALTO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex”), a nearly 100% (or over 99.9%) majority-owned…
SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare…
SAN MATEO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- Truepill, the digital health platform connecting telehealth, diagnostics, and pharmacy infrastructure…